APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Stem Cell Therapy

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.

Selected research

Market Outlook & Growth Opportunities

Global Stem Cell Therapy Market Outlook and Growth Opportunities 2026

Report ID 173895540426 December 2025192 pages

Choose your research edition.

Industry ResearchStem Cell Therapy Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Stem Cell Therapy Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Stem Cell Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Stem Cell Therapy Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Stem Cell Therapy Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.

North America is the largest Stem Cell Therapy market with about 65% market share. Europe is follower, accounting for about 16% market share.

The key players are Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell, Medi-post, Anterogen, Molmed, Takeda (TiGenix) etc. Top 3 companies occupied about 38% market share.

Read the full market overview

This report provides an overview of the global Stem Cell Therapy market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Stem Cell Therapy and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Stem Cell Therapy revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Stem Cell Therapy market.

Stem Cell Therapy Segment by Company

Osiris Therapeutics

NuVasive

Chiesi Pharmaceuticals

JCR Pharmaceutical

Pharmicell

Medi-post

Anterogen

Molmed

Takeda (TiGenix)

Stem Cell Therapy Segment by Type

Autologous

Allogeneic

Stem Cell Therapy Segment by Application

Musculoskeletal Disorder

Wounds & Injuries

Cornea

Cardiovascular Diseases

Others

Stem Cell Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Stem Cell Therapy status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Stem Cell Therapy key companies, revenue, market share, and recent developments.

3. To split the Stem Cell Therapy breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Stem Cell Therapy market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Stem Cell Therapy significant trends, drivers, influence factors in global and regions.

6. To analyze Stem Cell Therapy competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stem Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Stem Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stem Cell Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Stem Cell Therapy industry.

Chapter 3: Detailed analysis of Stem Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Stem Cell Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Stem Cell Therapy in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Stem Cell Therapy Industry Trends Table 2. Stem Cell Therapy Industry Drivers Table 3. Stem Cell Therapy Industry Opportunities and Challenges Table 4. Stem Cell Therapy Industry Restraints Table 5. Global Stem Cell Therapy Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Stem Cell Therapy Revenue Share by Company (2021-2026) Table 7. Global Stem Cell Therapy Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Stem Cell Therapy Key Company Manufacturing Base & Headquarters Table 9. Global Stem Cell Therapy Company, Product Type & Application Table 10. Global Stem Cell Therapy Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Stem Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Autologous Table 15. Significant Companies of Allogeneic Table 16. Global Stem Cell Therapy Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Stem Cell Therapy Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Stem Cell Therapy Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Stem Cell Therapy Sales Value Share by Type (2021-2026) Table 20. Global Stem Cell Therapy Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Musculoskeletal Disorder Table 22. Significant Companies of Wounds & Injuries Table 23. Significant Companies of Cornea Table 24. Significant Companies of Cardiovascular Diseases Table 25. Significant Companies of Others Table 26. Global Stem Cell Therapy Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Stem Cell Therapy Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Stem Cell Therapy Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Stem Cell Therapy Sales Value Share by Application (2021-2026) Table 30. Global Stem Cell Therapy Sales Value Share by Application (2027-2032) Table 31. Global Stem Cell Therapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Stem Cell Therapy Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Stem Cell Therapy Sales Value Share by Region (2021-2026) Table 34. Global Stem Cell Therapy Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Stem Cell Therapy Sales Value Share by Region (2027-2032) Table 36. Global Stem Cell Therapy Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Stem Cell Therapy Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Stem Cell Therapy Sales Value Market Share by Country (2021-2026) Table 39. Global Stem Cell Therapy Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Stem Cell Therapy Sales Value Market Share by Country (2027-2032) Table 41. Osiris Therapeutics Company Information Table 42. Osiris Therapeutics Business Overview Table 43. Osiris Therapeutics Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Osiris Therapeutics Stem Cell Therapy Product Portfolio Table 45. Osiris Therapeutics Recent Development Table 46. NuVasive Company Information Table 47. NuVasive Business Overview Table 48. NuVasive Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. NuVasive Stem Cell Therapy Product Portfolio Table 50. NuVasive Recent Development Table 51. Chiesi Pharmaceuticals Company Information Table 52. Chiesi Pharmaceuticals Business Overview Table 53. Chiesi Pharmaceuticals Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Chiesi Pharmaceuticals Stem Cell Therapy Product Portfolio Table 55. Chiesi Pharmaceuticals Recent Development Table 56. JCR Pharmaceutical Company Information Table 57. JCR Pharmaceutical Business Overview Table 58. JCR Pharmaceutical Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. JCR Pharmaceutical Stem Cell Therapy Product Portfolio Table 60. JCR Pharmaceutical Recent Development Table 61. Pharmicell Company Information Table 62. Pharmicell Business Overview Table 63. Pharmicell Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Pharmicell Stem Cell Therapy Product Portfolio Table 65. Pharmicell Recent Development Table 66. Medi-post Company Information Table 67. Medi-post Business Overview Table 68. Medi-post Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Medi-post Stem Cell Therapy Product Portfolio Table 70. Medi-post Recent Development Table 71. Anterogen Company Information Table 72. Anterogen Business Overview Table 73. Anterogen Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Anterogen Stem Cell Therapy Product Portfolio Table 75. Anterogen Recent Development Table 76. Molmed Company Information Table 77. Molmed Business Overview Table 78. Molmed Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Molmed Stem Cell Therapy Product Portfolio Table 80. Molmed Recent Development Table 81. Takeda (TiGenix) Company Information Table 82. Takeda (TiGenix) Business Overview Table 83. Takeda (TiGenix) Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Takeda (TiGenix) Stem Cell Therapy Product Portfolio Table 85. Takeda (TiGenix) Recent Development Table 86. Research Programs/Design for This Report Table 87. Authors List of This Report Table 88. Secondary Sources Table 89. Primary Sources List of Figures Figure 1. Stem Cell Therapy Product Image Figure 2. Global Stem Cell Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 4. Global Stem Cell Therapy Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Autologous Image Figure 8. Allogeneic Image Figure 9. Global Stem Cell Therapy Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Stem Cell Therapy Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Stem Cell Therapy Sales Value Share by Type (2021-2032) Figure 12. Musculoskeletal Disorder Image Figure 13. Wounds & Injuries Image Figure 14. Cornea Image Figure 15. Cardiovascular Diseases Image Figure 16. Others Image Figure 17. Global Stem Cell Therapy Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Stem Cell Therapy Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Stem Cell Therapy Sales Value Share by Application (2021-2032) Figure 20. Global Stem Cell Therapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Stem Cell Therapy Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Stem Cell Therapy Sales Value (2021-2032) & (US$ Million) Figure 23. North America Stem Cell Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Stem Cell Therapy Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Stem Cell Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Stem Cell Therapy Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Stem Cell Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Stem Cell Therapy Sales Value (2021-2032) & (US$ Million) Figure 29. South America Stem Cell Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Stem Cell Therapy Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Stem Cell Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Autologous
  • Allogeneic
Applications
  • Musculoskeletal Disorder
  • Wounds & Injuries
  • Cornea
  • Cardiovascular Diseases
  • Others
Companies covered
  • Osiris Therapeutics
  • NuVasive
  • Chiesi Pharmaceuticals
  • JCR Pharmaceutical
  • Pharmicell
  • Medi-post
  • Anterogen
  • Molmed
  • Takeda (TiGenix)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Stem Cell Therapy Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Stem Cell Therapy Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Stem Cell Therapy Market Dynamics
  1. 2.1 Stem Cell Therapy Industry Trends
  2. 2.2 Stem Cell Therapy Industry Drivers
  3. 2.3 Stem Cell Therapy Industry Opportunities and Challenges
  4. 2.4 Stem Cell Therapy Industry Restraints
3 Stem Cell Therapy Market by Company
  1. 3.1 Global Stem Cell Therapy Company Revenue Ranking in 2025
  2. 3.2 Global Stem Cell Therapy Revenue by Company (2021-2026)
  3. 3.3 Global Stem Cell Therapy Company Ranking (2024-2026)
  4. 3.4 Global Stem Cell Therapy Company Manufacturing Base and Headquarters
  5. 3.5 Global Stem Cell Therapy Company Product Type and Application
  6. 3.6 Global Stem Cell Therapy Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Stem Cell Therapy Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Stem Cell Therapy Market by Type
  1. 4.1 Stem Cell Therapy Type Introduction
  2. 4.1.1 Autologous
  3. 4.1.2 Allogeneic
  4. 4.2 Global Stem Cell Therapy Sales Value by Type
  5. 4.2.1 Global Stem Cell Therapy Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Stem Cell Therapy Sales Value by Type (2021-2032)
  7. 4.2.3 Global Stem Cell Therapy Sales Value Share by Type (2021-2032)
5 Stem Cell Therapy Market by Application
  1. 5.1 Stem Cell Therapy Application Introduction
  2. 5.1.1 Musculoskeletal Disorder
  3. 5.1.2 Wounds & Injuries
  4. 5.1.3 Cornea
  5. 5.1.4 Cardiovascular Diseases
  6. 5.1.5 Others
  7. 5.2 Global Stem Cell Therapy Sales Value by Application
  8. 5.2.1 Global Stem Cell Therapy Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Stem Cell Therapy Sales Value by Application (2021-2032)
  10. 5.2.3 Global Stem Cell Therapy Sales Value Share by Application (2021-2032)
6 Stem Cell Therapy Regional Value Analysis
  1. 6.1 Global Stem Cell Therapy Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Stem Cell Therapy Sales Value by Region (2021-2032)
  3. 6.2.1 Global Stem Cell Therapy Sales Value by Region: 2021-2026
  4. 6.2.2 Global Stem Cell Therapy Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Stem Cell Therapy Sales Value (2021-2032)
  7. 6.3.2 North America Stem Cell Therapy Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Stem Cell Therapy Sales Value (2021-2032)
  10. 6.4.2 Europe Stem Cell Therapy Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Stem Cell Therapy Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Stem Cell Therapy Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Stem Cell Therapy Sales Value (2021-2032)
  16. 6.6.2 South America Stem Cell Therapy Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Stem Cell Therapy Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Stem Cell Therapy Sales Value Share by Country, 2025 VS 2032
7 Stem Cell Therapy Country-level Value Analysis
  1. 7.1 Global Stem Cell Therapy Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Stem Cell Therapy Sales Value by Country (2021-2032)
  3. 7.2.1 Global Stem Cell Therapy Sales Value by Country (2021-2026)
  4. 7.2.2 Global Stem Cell Therapy Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Osiris Therapeutics
  2. 8.1.1 Osiris Therapeutics Company Information
  3. 8.1.2 Osiris Therapeutics Business Overview
  4. 8.1.3 Osiris Therapeutics Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Osiris Therapeutics Stem Cell Therapy Product Portfolio
  6. 8.1.5 Osiris Therapeutics Recent Developments
  7. 8.2 NuVasive
  8. 8.2.1 NuVasive Company Information
  9. 8.2.2 NuVasive Business Overview
  10. 8.2.3 NuVasive Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  11. 8.2.4 NuVasive Stem Cell Therapy Product Portfolio
  12. 8.2.5 NuVasive Recent Developments
  13. 8.3 Chiesi Pharmaceuticals
  14. 8.3.1 Chiesi Pharmaceuticals Company Information
  15. 8.3.2 Chiesi Pharmaceuticals Business Overview
  16. 8.3.3 Chiesi Pharmaceuticals Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Chiesi Pharmaceuticals Stem Cell Therapy Product Portfolio
  18. 8.3.5 Chiesi Pharmaceuticals Recent Developments
  19. 8.4 JCR Pharmaceutical
  20. 8.4.1 JCR Pharmaceutical Company Information
  21. 8.4.2 JCR Pharmaceutical Business Overview
  22. 8.4.3 JCR Pharmaceutical Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  23. 8.4.4 JCR Pharmaceutical Stem Cell Therapy Product Portfolio
  24. 8.4.5 JCR Pharmaceutical Recent Developments
  25. 8.5 Pharmicell
  26. 8.5.1 Pharmicell Company Information
  27. 8.5.2 Pharmicell Business Overview
  28. 8.5.3 Pharmicell Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pharmicell Stem Cell Therapy Product Portfolio
  30. 8.5.5 Pharmicell Recent Developments
  31. 8.6 Medi-post
  32. 8.6.1 Medi-post Company Information
  33. 8.6.2 Medi-post Business Overview
  34. 8.6.3 Medi-post Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Medi-post Stem Cell Therapy Product Portfolio
  36. 8.6.5 Medi-post Recent Developments
  37. 8.7 Anterogen
  38. 8.7.1 Anterogen Company Information
  39. 8.7.2 Anterogen Business Overview
  40. 8.7.3 Anterogen Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Anterogen Stem Cell Therapy Product Portfolio
  42. 8.7.5 Anterogen Recent Developments
  43. 8.8 Molmed
  44. 8.8.1 Molmed Company Information
  45. 8.8.2 Molmed Business Overview
  46. 8.8.3 Molmed Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Molmed Stem Cell Therapy Product Portfolio
  48. 8.8.5 Molmed Recent Developments
  49. 8.9 Takeda (TiGenix)
  50. 8.9.1 Takeda (TiGenix) Company Information
  51. 8.9.2 Takeda (TiGenix) Business Overview
  52. 8.9.3 Takeda (TiGenix) Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Takeda (TiGenix) Stem Cell Therapy Product Portfolio
  54. 8.9.5 Takeda (TiGenix) Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst